Tabbi-Anneni, Imène <br/><br/>
Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover?  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Mar 2003 
 - 1003-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.102.042143  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Heart Failure--blood<br/>Male<br/>Natriuretic Peptide, Brain--blood<br/>Organ Size<br/>Phospholipids--metabolism<br/>Rats<br/>Rats, Wistar<br/>Receptors, Adrenergic--metabolism<br/>Trimetazidine--therapeutic use<br/>Vasodilator Agents--therapeutic use